State AL
Clinical Trials in Alabama
Alabama is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Alabama and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 190 actively recruiting studies with Alabama sites out of 190 registered in total. The busiest research areas in Alabama are B Acute Lymphoblastic Leukemia, Atopic Dermatitis, Multiple Sclerosis. Leading sponsors running trials in the state include University of Alabama at Birmingham, National Cancer Institute (NCI), Novartis Pharmaceuticals. By stage, Alabama trials break down as Phase 1 (26), Phase 2 (54), Phase 3 (47), Phase 4 (5).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Alabama
Frequently Asked Questions — Clinical Trials in Alabama
How many clinical trials are currently recruiting in Alabama?
ClinicalMetric currently tracks 190 actively recruiting clinical trials with at least one location in Alabama. The total number of registered studies—including active but not currently enrolling trials—is 190. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Alabama?
Alabama hosts clinical trials across a broad range of medical conditions, including B Acute Lymphoblastic Leukemia, Atopic Dermatitis, Multiple Sclerosis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alabama serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Alabama?
To join a clinical trial in Alabama, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alabama maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Alabama
NCT07352592 N/A
Recruiting
Process-Based Approach Case Series For Anxiety Problems
Condition
Anxiety
Enrollment
10 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT07258849 Phase 1
Recruiting
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Ar...
Condition
Rheumatoid Arthritis (RA)
Enrollment
141 pts
Location
United States, Germany
Sponsor
Eli Lilly and Company
NCT06819878 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy W...
Condition
Moderately to Severely Active Crohns Disease
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07136012 Phase 3
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)...
Condition
Cardiovascular Disease
Enrollment
11,000 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT06632444 Phase 3
Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease...
Condition
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Enrollment
1,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05812807 Phase 3
Recruiting
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who H...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
1,295 pts
Location
United States, Canada, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
NCT05283265 N/A
Recruiting
Neurophysiological Mechanisms of Language Comprehension
Condition
Language Disorders
Enrollment
153 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
900 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
NCT06917911 Phase 2
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatm...
Condition
Core Binding Factor Acute Myeloid Leukemia
Enrollment
162 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06873945 Phase 3
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alop...
Condition
Alopecia Areata
Enrollment
1,330 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT06638801 N/A
Recruiting
Brain Uptrain to Improve Learning and Development
Condition
Term Infant
Enrollment
188 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06712407 Phase 4
Recruiting
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Pati...
Condition
IgA Nephropathy
Enrollment
60 pts
Location
United States, Puerto Rico
Sponsor
Calliditas Therapeutics AB
NCT07194044 Phase 1
Recruiting
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Condition
Metastatic Ewing Sarcoma
Enrollment
15 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT06430801 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Partici...
Condition
Crohn's Disease
Enrollment
1,200 pts
Location
United States, Australia, Austria
Sponsor
Merck Sharp & Dohme LLC
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06338995 Phase 3
Recruiting
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis ...
Condition
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Enrollment
510 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT05059444 N/A
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Condition
Bladder Carcinoma
Enrollment
2,285 pts
Location
United States, France, Germany
Sponsor
Guardant Health, Inc.
NCT06095128 Phase 4
Recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Condition
Ulcerative Colitis
Enrollment
65 pts
Location
United States, Canada
Sponsor
Takeda
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT07690189 Phase 1
Recruiting
Study of NTB-928 in R/R OC
Condition
Relapsed/Refractory Ovarian Carcinoma
Enrollment
90 pts
Location
United States
Sponsor
TeneoSeven, Inc.
NCT07284784 Phase 2, Phase 3
Recruiting
A Study of Buntanetap in Participants With PD
Condition
Parkinson's Disease (PD)
Enrollment
500 pts
Location
United States
Sponsor
Annovis Bio Inc.
NCT07161726 Phase 1, Phase 2
Recruiting
Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial
Condition
Mobility Disability
Enrollment
36 pts
Location
United States
Sponsor
University of Alabama at Birmi
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology